Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-16
2005-08-16
Henley, III, Raymond (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06930121
ABSTRACT:
Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
REFERENCES:
patent: 2933502 (1960-04-01), Klopping
patent: 3010968 (1961-11-01), Loux
patent: 3370957 (1968-02-01), Wagner et al.
patent: 3399212 (1968-08-01), Hoover et al.
patent: 3480642 (1969-11-01), Stedman et al.
patent: 3499761 (1970-03-01), Dersch et al.
patent: 3541213 (1970-11-01), Klopping
patent: 3574845 (1971-04-01), Actor et al.
patent: 3669969 (1972-06-01), Lunn
patent: 3738995 (1973-06-01), Adams et al.
patent: RE28403 (1975-04-01), Actor et al.
patent: 3881014 (1975-04-01), Regel et al.
patent: 3933846 (1976-01-01), Daum
patent: 3956262 (1976-05-01), Heyes et al.
patent: 4001423 (1977-01-01), Dodds
patent: 4046906 (1977-09-01), Frensch et al.
patent: 4053598 (1977-10-01), Daum et al.
patent: 4086235 (1978-04-01), Beard
patent: 4731366 (1988-03-01), Munro et al.
patent: 4814329 (1989-03-01), Harsanyi et al.
patent: 5098923 (1992-03-01), Karjalainen et al.
patent: 5114951 (1992-05-01), King
patent: 5149527 (1992-09-01), Weisenthal
patent: 5284662 (1994-02-01), Koparkar et al.
patent: 5290801 (1994-03-01), Higley et al.
patent: 5310748 (1994-05-01), Wilde et al.
patent: 5329012 (1994-07-01), Anderson
patent: 5364875 (1994-11-01), Wilde
patent: 5434163 (1995-07-01), Edlind et al.
patent: 5441742 (1995-08-01), Autant et al.
patent: 5554373 (1996-09-01), Seabrook et al.
patent: 5629341 (1997-05-01), Camden
patent: 5656615 (1997-08-01), Camden
patent: 5665713 (1997-09-01), Camden
patent: 5665751 (1997-09-01), Camden
patent: 5767138 (1998-06-01), Camden
patent: 5770616 (1998-06-01), Camden
patent: 5840742 (1998-11-01), Camden
patent: 5854231 (1998-12-01), Camden
patent: 5872142 (1999-02-01), Camden
patent: 5880144 (1999-03-01), Camden
patent: 5900429 (1999-05-01), Camden
patent: 5902804 (1999-05-01), Camden
patent: 5908855 (1999-06-01), Camden
patent: 5929099 (1999-07-01), Camden
patent: 5932604 (1999-08-01), Camden
patent: 5932609 (1999-08-01), Camden
patent: 5958950 (1999-09-01), Padia et al.
patent: 6025377 (2000-02-01), Camden
patent: 6077862 (2000-06-01), Camden
patent: 6090796 (2000-07-01), Camden
patent: 6110953 (2000-08-01), Camden
patent: 6136835 (2000-10-01), Camden
patent: RE37003 (2000-12-01), Camden
patent: 6177460 (2001-01-01), Camden
patent: 6200992 (2001-03-01), Camden
patent: 6211177 (2001-04-01), Sperl et al.
patent: 6228876 (2001-05-01), Camden
patent: 6245789 (2001-06-01), Camden
patent: 6251870 (2001-06-01), Camden
patent: 6262093 (2001-07-01), Camden
patent: 6265427 (2001-07-01), Camden
patent: 6271217 (2001-08-01), Camden
patent: 6290929 (2001-09-01), Camden
patent: 6329355 (2001-12-01), Camden
patent: 6362207 (2002-03-01), Camden
patent: 6380232 (2002-04-01), Quada, Jr. et al.
patent: 6384049 (2002-05-01), Camden
patent: 6407105 (2002-06-01), Quada, Jr. et al.
patent: 6407131 (2002-06-01), Quada, Jr. et al.
patent: 6420411 (2002-07-01), Camden et al.
patent: 6423734 (2002-07-01), Camden
patent: 6423735 (2002-07-01), Camden et al.
patent: 6423736 (2002-07-01), Camden et al.
patent: 6462062 (2002-10-01), Camden et al.
patent: 6479526 (2002-11-01), Camden
patent: 6482843 (2002-11-01), Quada, Jr. et al.
patent: 2001/0002403 (2001-05-01), Camden
patent: 2001/0027205 (2001-10-01), Camden
patent: 2001/0039291 (2001-11-01), Camden
patent: 2001/0041678 (2001-11-01), Camden
patent: 2001/0047015 (2001-11-01), Camden
patent: 2001/0053773 (2001-12-01), Camden
patent: 2002/0019415 (2002-02-01), Camden
patent: 667158 (1965-11-01), None
patent: 2144505 (1973-03-01), None
patent: 0617968 (1994-10-01), None
patent: 2046114 (1971-03-01), None
patent: 2155888 (1973-10-01), None
patent: 1123317 (1968-08-01), None
patent: 1296561 (1972-11-01), None
patent: 1397886 (1975-06-01), None
patent: 158878 (1987-02-01), None
patent: 159210 (1987-04-01), None
patent: S42-23274 (1963-05-01), None
patent: 51042565 (1975-11-01), None
patent: 51034161 (1976-03-01), None
patent: H06-505733 (1994-06-01), None
patent: 07277956 (1995-10-01), None
patent: WO 94/04541 (1994-03-01), None
patent: WO 96/32103 (1996-10-01), None
patent: WO 96/32104 (1996-10-01), None
patent: WO 96/32107 (1996-10-01), None
patent: WO 96/32115 (1996-10-01), None
patent: WO 96/40119 (1996-12-01), None
patent: WO 96/40120 (1996-12-01), None
patent: WO 96/40122 (1996-12-01), None
patent: WO 97/05870 (1997-02-01), None
patent: WO 97/05872 (1997-02-01), None
patent: WO 97/05873 (1997-02-01), None
patent: WO 98/32440 (1998-07-01), None
patent: WO 98/51303 (1998-11-01), None
patent: WO 98/51304 (1998-11-01), None
patent: WO 99/59585 (1999-11-01), None
patent: WO 00/13511 (2000-03-01), None
patent: WO 00/21504 (2000-04-01), None
patent: WO 00/50007 (2000-08-01), None
patent: WO 01/12169 (2001-02-01), None
patent: WO 01/83457 (2001-11-01), None
patent: WO 01/89499 (2001-11-01), None
patent: WO 02/09715 (2002-02-01), None
patent: WO 02/09716 (2002-02-01), None
patent: WO 02/26716 (2002-04-01), None
patent: WO 02/41891 (2002-05-01), None
Hayden, Frederick G., “Antimicrobial Agents”,Goodman&Gilman's, The Pharmacological Basis of Therapeutics, Ninth Edition, (1996), pp. 1191-1193; The McGraw-Hill Companies.
Pending Application of Camden, U.S. Appl. No. 08/857,811, filed May 16, 1997. (6643).
Pending Application of Camden, U.S. Appl. No. 09/645,427, filed Aug. 24, 2000. (5785D2RD2).
Pending Application of Camden, U.S. Appl. No. 09/676,034, filed Sep. 29, 2000. (6643R2).
Pending Application of Camden, U.S. Appl. No. 09/676,032, filed Sep. 29, 2000. (6643R5).
Pending Application of Camden, U.S. Appl. No. 09/676,031, filed Sep. 29, 2000. (6643R6).
Pending Application of Camden, U.S. Appl. No. 09/670,166, filed Sep. 26, 2000. (8253).
Pending Application of Camden, U.S. Appl. No. 09/703,955, filed Nov. 1, 2000. (8315).
Pending Application of Camden, U.S. Appl. No. 10/132,545, filed Apr. 25, 2002 (8252D).
Pending Application of Camden, U.S. Appl. No. 10/106,429, filed Jul. 18, 2002 (7719C).
Pending Application of Camden, U.S. Appl. No. 10/267,051, filed Oct. 8, 2002 (8251D).
Pending Application of Camden, U.S. Appl. No. 10/280,100, filed Oct. 24, 2002 (8315C).
Pending Application of Camden, U.S. Appl. No. 10/288,264, filed Nov. 5, 2002 (5638D2CDC2).
CA Registry No., 83601-82-5, (1982), American Chemical Society, (abstract only).
Agarwal, et al., “Antiparasitic agents. Part XVI. Synthesis of 5(6)-substituted benzimidazole-2-carbamates as anthelmintic agents”, Indian J. Chem., Sect. B, 32B(4), pp. 453-456, (1993), American Chemical Society, (abstract only).
Agarwal, et al., “Segregation of activity profile in benzimidazoles: Effect of spacers at 5(6)-position of methyl benzimidazole-2-carbamates”, Z. Naturforsch., C: Biosci., 48(11-12), pp. 829-838, (1993), American Chemical Society, (abstract only).
Agarwal, et al., “Synthesis of 2-substituted 5(6)-aroylaminobenzimidazoles as potential anthelmintics”, Indian J. Chem., Sect. B, 22B(2), pp. 146-149, (1983), American Chemical Society (abstract only).
Atassi, et al., “R17934-NSC 238159: A New Antitumor Drug”, pp. 599-607, (1975), Europ. J. Cancer, vol. 11, Pergamon Press.
Aur, “Treatment fo Parasitic Infestation in Children with Malignant Neoplams” pp. 129-131, (1971), The Journal of Pediatrics, vol. 78, No. 1, Mosby, Inc.
Beard, “5(6)-Benzeme ring-substituted benzimidazole-2-carbamate derivative having anthelmintic activity”, U.S. Appl. No. 4,086,235 A, (1978), American Chemical Society (abstract only).
Bekish, et al., “Search for active drugs from a group of benzimidazolecarbamates for the treatment of trichinosis”, Vitebsk. Med. Inst., Vitebsk, USSR, Med. Parazitol. Parazit. Bolezni, pp. 32-35, (1979), American Chemical Society (abstract only).
Delatour, et al., “Oncology- Embryotoxic and Antimitotic Properties of Parbendazole, Mebendazole, and Cambendazole”
Agyin Joseph K.
Camden James Berger
Quada, Jr. James C.
Delacroix-Muirheid Cybille
Haynes and Boone LLP
Henley III Raymond
UAF Technologies and Research, LLC
LandOfFree
Compounds and methods for use thereof in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for use thereof in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for use thereof in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3502492